TENSHA THERAPEUTICS INC has a total of 42 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2015. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are ENDACEA INC, AKHAPKINA VALENTINA IVANOVNA and MS THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Israel | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Mexico | 3 | |
#8 | United States | 3 | |
#9 | WIPO (World Intellectual Property Organization) | 3 | |
#10 | Brazil | 2 | |
#11 | Hong Kong | 2 | |
#12 | Singapore | 2 | |
#13 | Argentina | 1 | |
#14 | Chile | 1 | |
#15 | Costa Rica | 1 | |
#16 | EAPO (Eurasian Patent Organization) | 1 | |
#17 | Japan | 1 | |
#18 | Peru | 1 | |
#19 | Philippines | 1 | |
#20 | Russian Federation | 1 | |
#21 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Landau Steven B | 31 |
#2 | Kagey Michael | 23 |
#3 | Kagey Michael H | 8 |
#4 | Steven B Landau | 7 |
#5 | Michael Kagey | 4 |
#6 | Michael H Kagey | 3 |
Publication | Filing date | Title |
---|---|---|
CN107787227A | The treatment of NUT center line cancers | |
AU2015339511A1 | Bromodomain inhibitors | |
CN106456653A | Treatment of conditions associated with hyperinsulinaemia |